LGALS3 and cardiac hypertrophy: After chronic infusion of angiotensin II (ANG II), Gal-3 KO mice showed reduced infiltration cardiac macrophages and inflammation, leading to improved cardiac function and reduced fibrosis, albeit no effect on cardiac hypertrophy and blood pressure was observed (Gonzalez et al., 2016).